Protein Lactylation and Inflammation: A Metabolic‑Driven PTM Serving as Molecular Timer for Immune Responses

Lactate Repositioned: From Glycolytic Waste Product to Immunomodulatory Brake Signal

Immune‑cell activation triggers pronounced metabolic reprogramming featuring sharply elevated glycolytic flux and abundant lactate biosynthesis. For many decades, lactate was merely categorized as acidic disposable metabolic waste within inflammatory biological contexts. Landmark 2019 research work from Yingming Zhao’s research team uncovered lysine lactylation as an unreported protein post‑translational modification utilizing lactate as biochemical precursor molecule. Additional parallel publications from the same period further validated lactate‑driven active immunomodulatory functions capable of constraining excessive inflammatory cascades and restoring cellular homeostatic states. These collective findings construct new conceptual frameworks interconnecting cellular metabolism, epigenetic regulation and multi‑layered inflammatory‑response signalling networks.

Writer‑Eraser Regulatory Circuits Govern Time‑Dependent Lactylation Dynamics in Macrophages

Lysine lactylation modification undergoes reversible modulation orchestrated by dedicated writer and eraser enzymatic components. p300/CBP acetyltransferase complexes function as primary writer enzymes mediating lactyl‑moiety transfer onto target lysine residues. HDAC1‑3 family members exhibit intrinsic de‑lactylation catalytic capacity to reverse this covalent protein alteration. In macrophage‑polarization experimental systems, researchers have documented the so‑called “lactate‑timer” biological phenomenon. At early inflammatory‑stimulation phases, NF‑κB‑driven signalling dominates transcriptional programmes for pro‑inflammatory gene expression. As intracellular lactate concentrations gradually accumulate over time, histone lactylation gains functional prominence at promoter loci of tissue‑repair‑associated genes such as Arg1 and Il10. This chronological molecular switch enables smooth transition from immune‑attack‑oriented states toward inflammation‑resolution phenotypes and prevents persistent pathological inflammatory tissue injury.

Direct Inhibitory Effects of Lactylation‑Associated Signals Upon RLR‑MAVS Innate Immune Axis

Lactate‑linked regulatory outputs are not confined exclusively to chromatin‑based epigenetic transcriptional reshaping. Independent research published by Zhang and co‑workers described direct molecular interference targeting mitochondrial antiviral‑signalling‑protein (MAVS). Elevated cytosolic lactate concentrations interact with MAVS transmembrane domains, diminishing mitochondrial membrane localization and physical interaction events with upstream RIG‑I sensor molecules. Such molecular disturbance suppresses downstream type‑I interferon (IFN‑β) production independent of intracellular pH fluctuation changes. This biochemical mechanism fulfils physiological roles within antiviral immunity, where glycolysis‑derived lactate constrains over‑amplified interferon‑mediated immune activation. Tumour‑microenvironment‑generated high lactate can hijack this identical biochemical pathway to dampen anti‑tumour innate‑immune effector responses.

Lactylation‑Mediated Immune Remodelling in Tumour‑Associated Macrophages and Efferocytosis Processes

Within tumour‑microenvironment niches, tumour‑cell‑originated lactate is internalized by tumour‑associated macrophages and triggers mTORC1 signalling‑cascade activation. This signalling event down‑regulates TFEB transcription factor alongside its downstream target ATP6V0D2 transcript abundance, leading to stabilized HIF‑2α protein levels. Stabilized HIF‑2α subsequently initiates transcription of M2‑like homeostatic gene modules including Vegf, Arg1 and Mrc1. Lactate‑triggered intracellular acidification also acts via G‑protein‑coupled‑receptor‑cAMP signalling axes to up‑regulate CREM transcriptional repressor molecules and repress pro‑inflammatory Tnf and Nos2 gene expression. Efferocytosis, the phagocytic clearance of apoptotic cellular corpses, also boosts glycolytic activity and lactate secretion. Paracrine lactate signalling then elevates anti‑inflammatory transcripts Tgfb and Il10 to reinforce local inflammation‑resolving micro‑environmental conditions.

Research Outlook for Lactylation‑Focused Immunometabolism Basic‑Research

Protein lactylation and upstream lactate‑metabolic signalling constitute central molecular bridges linking cellular metabolic status to multi‑phase inflammatory‑response outputs. Mechanistic layers range from direct RLR‑MAVS innate‑signal attenuation, histone‑mediated epigenetic transcriptional reprogramming to macrophage phenotypic‑state remodelling. Comprehensive dissection of cell‑type‑specific lactylation substrate repertoires and temporally‑resolved writer‑eraser network behaviours will advance mechanistic comprehension of infection, auto‑immunity and tumour‑associated inflammatory processes. High‑quality pan‑lactyl‑lysine immunological reagents form essential experimental infrastructure for global lactyl‑proteome profiling and candidate‑substrate functional validation in immunometabolism‑oriented laboratory investigations.

Lactylation‑Targeted Immuno‑Detection & Enrichment Reagents from ANT BIO PTE. LTD

ANT BIO PTE. LTD supplies unconjugated pan‑L‑lactyllysine antibody and two grades of anti‑L‑lactyllysine immuno‑affinity agarose beads for inflammation‑immunometabolism‑focused lactyl‑proteomics basic‑research assignments. Every reagent batch undergoes peptide‑array epitope‑specificity screening and multi‑assay functional‑validation before commercial release.

Catalog Table of Anti‑L‑Lactyllysine Research Reagents

Functional‑Validation Characteristics of ANT BIO PTE. LTD Lactylation‑Focused Reagents

S0B0719 polyclonal antibody selectively recognizes L‑lactyl‑modified lysine epitopes with minimal cross‑reactivity toward analogous short‑chain acyl‑lysine peptide variants. S0F0003 standard‑grade beads and S0F0016 premium‑grade beads transfer this epitope‑selectivity onto solid‑phase peptide‑enrichment workflows. Premium‑grade resin possesses elevated antibody‑coupling density for processing low‑abundance peptide starting material. Validated sample matrices include digested peptide lysates from activated‑macrophage cultures, immune‑cell pellets and inflammatory‑model frozen tissue homogenates. Qualified experimental workflows contain immunoblot global‑modification monitoring, peptide immuno‑precipitation enrichment and LC‑MS‑coupled large‑scale lactyl‑proteomic profiling assays.

Core Fundamental‑Research Applications for Lactylation‑Targeted Reagent Panel

1. Global lactyl‑proteomic profiling by anti‑L‑lactyllysine bead‑based peptide enrichment coupled with high‑resolution LC‑MS/MS workflows

2. Comparative lactylation‑landscape analysis across time‑series macrophage‑polarization and efferocytosis experimental‑model cohorts

3. Immunoblot‑level quantification of total‑protein lactylation shifts under glycolysis‑perturbation metabolic‑intervention conditions

4. Immuno‑enrichment‑assisted identification of non‑histone lactylation substrates participating in RLR‑MAVS innate‑immune signalling cascades

5. Mechanistic exploration of PTM‑crosstalk between lysine lactylation and acetylation within chromatin and cytoplasmic immune‑signal‑transduction networks

6. Orthogonal validation for candidate lactylation hits originating from multi‑omics screening datasets of inflammatory‑cell‑model biological specimens

Global Manufacturing & Compliance Standards

All anti‑lactyllysine antibody and immuno‑affinity bead batches complete peptide‑specificity profiling and multi‑platform functional‑performance verification prior to commercial‑product release. Manufacturing facilities adhere to ISO9001, ISO13485 and EU 98/79/EC certification specifications governing life‑science‑research‑reagent‑production‑protocols. In‑house application‑science teams supply detailed immuno‑enrichment‑assay SOP documents and curated immunometabolism‑lactylation‑research‑reference‑publication‑resources. The broader reagent ecosystem integrates additional PTM‑detection antibodies, ELISA kits and immuno‑affinity resins supporting comprehensive multi‑omics inflammation‑biology‑research pipelines.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANT BIO PTE. LTD., we are committed to advancing life science research through high‑quality, reliable reagents and comprehensive solutions. Our specialized sub‑brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer‑centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.